PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

Detalles Bibliográficos
Autores principales: Hamadani, M., Graham, C. N., Liao, L., Zhang, K. H., Strat, H., Ungar, D., Ai, W., Chen, L., Carlo-Stella, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431454/
http://dx.doi.org/10.1097/01.HS9.0000851308.42232.1f
_version_ 1784780059803910144
author Hamadani, M.
Graham, C. N.
Liao, L.
Zhang, K. H.
Strat, H.
Ungar, D.
Ai, W.
Chen, L.
Carlo-Stella, C.
author_facet Hamadani, M.
Graham, C. N.
Liao, L.
Zhang, K. H.
Strat, H.
Ungar, D.
Ai, W.
Chen, L.
Carlo-Stella, C.
author_sort Hamadani, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9431454
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94314542022-08-31 PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) Hamadani, M. Graham, C. N. Liao, L. Zhang, K. H. Strat, H. Ungar, D. Ai, W. Chen, L. Carlo-Stella, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431454/ http://dx.doi.org/10.1097/01.HS9.0000851308.42232.1f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Hamadani, M.
Graham, C. N.
Liao, L.
Zhang, K. H.
Strat, H.
Ungar, D.
Ai, W.
Chen, L.
Carlo-Stella, C.
PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_full PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_fullStr PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_full_unstemmed PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_short PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_sort pb2119: long-term survival projections of loncastuximab tesirine-treated patients in relapsed or refractory (r/r) diffuse large b-cell lymphoma (dlbcl)
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431454/
http://dx.doi.org/10.1097/01.HS9.0000851308.42232.1f
work_keys_str_mv AT hamadanim pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT grahamcn pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT liaol pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT zhangkh pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT strath pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT ungard pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT aiw pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT chenl pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT carlostellac pb2119longtermsurvivalprojectionsofloncastuximabtesirinetreatedpatientsinrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl

Ejemplares similares